Cargando…
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus
The down-regulation of miR-199 occurs in nearly all primary hepatocellular carcinomas (HCCs) and HCC cell lines in comparison with normal liver. We exploited this miR-199 differential expression to develop a conditionally replication-competent oncolytic adenovirus, Ad-199T, and achieve tumor-specifi...
Autores principales: | Callegari, Elisa, Elamin, Bahaeldin K., D’Abundo, Lucilla, Falzoni, Simonetta, Donvito, Giovanna, Moshiri, Farzaneh, Milazzo, Maddalena, Altavilla, Giuseppe, Giacomelli, Luciano, Fornari, Francesca, Hemminki, Akseli, Di Virgilio, Francesco, Gramantieri, Laura, Negrini, Massimo, Sabbioni, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771938/ https://www.ncbi.nlm.nih.gov/pubmed/24069256 http://dx.doi.org/10.1371/journal.pone.0073964 |
Ejemplares similares
-
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model
por: Callegari, Elisa, et al.
Publicado: (2018) -
Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2014) -
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
por: Callegari, Elisa, et al.
Publicado: (2018) -
Role of microRNAs in hepatocellular carcinoma: a clinical perspective
por: Callegari, Elisa, et al.
Publicado: (2013) -
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
por: Callegari, Elisa, et al.
Publicado: (2022)